Short anogenital distance is associated with testicular germ cell tumour development
Andrology2020Vol. 8(6), pp. 1770–1778
Citations Over Time
Daniel Moreno‐Mendoza, Elena Casamonti, Antoni Riera‐Escamilla, Sara Pietroforte, Giovanni Corona, E Ruiz-Castañé, Csilla Krausz
Abstract
Ours is the first study focusing on anogenital distances in testicular germ cell tumour patients. We identified short anogenital distances (which is a surrogate biomarker of androgen action during foetal life) as a significant risk factor for this disease. After further validation of our preliminary data, anogenital distance measurement could become part of testicular germ cell tumour screening in order to better define those individuals who would benefit from long-term active follow-up.
Related Papers
- → Anogenital Distance in Newborns with Hypospadias(2021)1 cited
- → Association between Anogenital Distance and External Genital Anomalies in Nigerian Newborn Infants(2018)1 cited
- → Re: Shorter Anogenital Distance Correlates with the Severity of Hypospadias in Pre-Pubertal Boys(2016)
- → Re: Prenatal Anogenital Distance is Shorter in Fetuses with Hypospadias(2017)